UBS Maintains Neutral on Carter's, Lowers Price Target to $38
UBS analyst Jay Sole maintains Carter's (NYSE:CRI) with a Neutral and lowers the price target from $41 to $38.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga